Abstract
The catastrophic effects of proliferative diabetic retinopathy and diabetic macular edema on the vision of patients with diabetes emphasize the importance of control of the diabetic process (1). The end stage of this process—namely, unresponsive macular edema, vitreous hemorrhage, and traction-related retinal detachment—can effectively be prevented and useful vision can be retained with timely laser photocoagulation. A logical goal is early detection of these complications because the efficacy of photocoagulation therapy depends on early treatment (2).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
